Patents Assigned to Incyte Holdings Cororation
  • Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
    Patent number: 11285140
    Abstract: The present invention provides piperidin-4-yl azetidine derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase 1 (JAK1) and are useful in the treatment of diseases related to the activity of JAK1 including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
    Type: Grant
    Filed: May 19, 2020
    Date of Patent: March 29, 2022
    Assignees: Incyte Corporation, Incyte Holdings Cororation
    Inventors: Taisheng Huang, Chu-Biao Xue